Ponatinix 45 Mg (Ponatinib) – 30 Tablets

$ 685.00

Ponatinix 45 Mg (Ponatinib) from Beacon Pharmaceuticals Ltd. – A beacon of hope on the road to superior cancer treatment Ponatinib – a World-Class Cancer Drug This is a revolutionizing medicine based on oncology – Beacon Pharmaceuticals Ltd’s commitment to provide world-class healthcare solutions against cancer. Ponatinix 45 mg is not only a step towards therapy but also hope for a cancer free world.

 

Ponatinix 45 mg (Ponatinib) is a prescription medication which is a kinase inhibitor indicated for the treatment:

  • Adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.
  • Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.

 

Product Feature:


ManufacturerBeacon Pharmaceuticals PLC.
Indication :  Antineoplastic (Cancer) Medicine.
Generic :  Ponatinib
Formulation :  Tablet
Pack Size :  30 Tablets
Strengths :  45 Mg
Storage :  Below 30°C

 

You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Ponatinix 45 Mg (Ponatinib) medicine.